Health Care Leader Nears Two Buy Points Following 55% Leap This Year

Group 1 - Alignment Healthcare (ALHC) has significantly outperformed the S&P 500 this year, with a membership growth that is attracting investor interest [1] - The stock is currently near two buy points and has been selected for IBD 50 Growth Stocks To Watch [1] - There is strong institutional support for Alignment Healthcare, which has seen its stock price increase by more than 55% this year [1] Group 2 - Alignment Healthcare has received an upgrade in its IBD Relative Strength Rating from 79 to 82, indicating improving price performance [2] - The company has reached a benchmark of an 80-plus Relative Strength Rating, reflecting its rising price performance [4] - The stock's Relative Strength Rating has seen a jump to 83, showcasing its strong market position [4]